STIPPLE BIO, INC.

Profile

Company Names

STIPPLE BIO, INC.

Addresses

238 MAIN STREET, CAMBRIDGE, MA 02142

2 SOUTH STREET, MILFORD, CT 06460

Phone Numbers

5099394681

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2021

State Incorporated:

DELAWARE

Total Amount Raised:

$86,581,083.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2026-03-31 
$65,130,013.00 
$100,200,007.00 
$35,069,994.00 
Equity 
2
2024-12-20 
$9,476,070.00 
$15,000,000.00 
$5,523,930.00 
Equity 
1
2022-05-31 
$11,975,000.00 
$12,000,000.00 
$25,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
VINEETA 
 
AGARWALA 
DIRECTOR
BIGHAT BIOSCIENCES, INC.   |  THYME CARE, INC.   |  WAYMARK, INC. / DE   |  STIPPLE BIO, INC.   |  REZO THERAPEUTICS, INC.   |  PEARL HEALTH, INC.   |  ARDA THERAPEUTICS, INC.   |  KNOWNWELL, INC.
DEREK 
 
DIROCCO 
DIRECTOR
WEREWOLF THERAPEUTICS, INC.   |  DAY ONE BIOPHARMACEUTICALS HOLDING CO LLC   |  ACRIVON THERAPEUTICS, INC.   |  MINERALYS THERAPEUTICS, INC.   |  RIVUS PHARMACEUTICALS, INC.   |  EVOMMUNE, INC.   |  BAMBUSA THERAPEUTICS, INC.   |  STIPPLE BIO, INC.
OWEN 
 
HUGHES 
DIRECTOR
RANA THERAPEUTICS, INC.   |  TRANSLATE BIO, INC.   |  CULLINAN MICA CORP.   |  REMEDY PLAN, INC.   |  IKENA ONCOLOGY, INC.   |  STIPPLE BIO, INC.
JEFFREY 
 
LANDAU 
EXECUTIVE OFFICER, DIRECTOR
STIPPLE BIO, INC.
AARON 
 
RING 
EXECUTIVE OFFICER, DIRECTOR
SIMCHA THERAPEUTICS HOLDING COMPANY, LLC   |  SERANOVA BIO, LLC   |  STIPPLE BIO, INC.   |  SERANOVA BIO, INC.
THILO 
 
SCHROEDER 
DIRECTOR
BLUEPRINT MEDICINES CORP   |  IMAGINAB, INC.   |  IDEAYA BIOSCIENCES, INC.   |  REVOLUTION MEDICINES, INC.   |  SILVERBACK THERAPEUTICS, INC.   |  CIRCLE PHARMA, INC.   |  ALTEROME THERAPEUTICS, INC.   |  NEXTECH VII ONCOLOGY SCSP   |  NEXTECH CROSSOVER I SCSP   |  NEXTECH VII CARRY SCSP   |  NEXTECH CROSSOVER I CARRY SCSP   |  NEXTECH VIII SCSP   |  STIPPLE BIO, INC.
GREG 
 
VERDINE 
DIRECTOR
STIPPLE BIO, INC.
ANTOINE 
 
YVER 
DIRECTOR
STIPPLE BIO, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2026-04-06
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2026-03-31 
2024-12-20
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2024-12-20 
2022-06-07
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-05-31 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#